Cimpress (CMPR)
(Delayed Data from NSDQ)
$90.78 USD
+1.62 (1.82%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $90.71 -0.07 (-0.08%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.78 USD
+1.62 (1.82%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $90.71 -0.07 (-0.08%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth B Momentum A VGM
Zacks News
Here's Why You Must Hold on to Cimpress (CMPR) Stock Now
by Zacks Equity Research
Cimpress (CMPR) benefits from a diversified business structure, acquired assets and investments focused on developing growth opportunities. However, rising costs and high debts remain concerning.
New Strong Sell Stocks for August 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Cimpress (CMPR) Loss Narrows in Q4 on Y/Y Sales Growth
by Zacks Equity Research
Cimpress' (CMPR) fourth-quarter fiscal 2018 loss narrows year over year on the back of solid organic sales growth and forex tailwinds.
Industrial Stock Earnings Slated for Aug 1: CMPR, BDC & More
by Zacks Equity Research
Strengthening global economy and expanding manufacturing sector in the U.S. should be conducive to growth for industrial companies.
Cimpress (CMPR) Down 2.3% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Cimpress (CMPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cimpress Aims to Mitigate Risks by Decentralizing Operations
by Zacks Equity Research
Cimpress' (CMPR) management has decentralized operations to improve accountability for customer satisfaction and capital returns, simplify decision-making and improve the speed of execution.
Apogee Rides on Growing Construction Market Amid Rising Cost
by Zacks Equity Research
Growing construction market and the focus on operational improvements, as well as the impact of the tax reform, are anticipated to drive Apogee???s (APOG) performance despite rising cost.
Emerson (EMR) to Distribute Dixell Products in United States
by Zacks Equity Research
Emerson Electric (EMR) announces the finalization of an agreement with Weiss Instruments to directly serve the customers of its Dixell brand.
Emerson's New Transmitter Simplifies Maintenance & Operation
by Zacks Equity Research
Emerson Electric (EMR) unveils the Rosemount 8712EM Wall Mount Magnetic Flow Meter Transmitter with powerful diagnostic capabilities and usability features.
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
Forget Market Volatility With These 5 Low-Beta Stocks
by Zacks Equity Research
We have figured out a proven strategy that says lucrative returns can also be earned from less-risky stocks if some other parameters are considered.
Eurozone Beats United States Again: 5 Hot Stock Picks
by Zacks Equity Research
5 Europe-based stocks to buy as the region scores decade-high growth rate in 2017.
Parker-Hannifin (PH) Introduces Low-Lead Solenoid Valves
by Zacks Equity Research
Parker-Hannifin (PH) launches a Low-Lead Brass body series of solenoid valves for beverage dispensing industry.
Zacks.com highlights: HCA Healthcare, Cimpress N.V. and Virtu Financial
by Zacks Equity Research
Zacks.com highlights: HCA Healthcare, Cimpress N.V. and Virtu Financial
3 Low-Beta Stocks to Ease Jitters From Market Volatility
by Zacks Equity Research
Our intense research has developed a strategy that allows investors to spend money on securities with lower risk and fetch attractive returns.
5 Must Buy Stocks After Volatility Explodes
by David Bartosiak
These five Zacks Rank #1 (Strong Buy) stocks are on sale after volatility exploded in the market.
Cimpress (CMPR) Jumps: Stock Rises 6.2%
by Zacks Equity Research
The shares of Cimpress (CMPR) rose 6.2% on Friday.
Cimpress (CMPR) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cimpress (CMPR) Q2 earnings decline due to significant rise in operating expenses despite top-line growth.
Industrial Stocks' Earnings on Jan 31: JCI, IR, AVY, CMPR
by Supriyo Bose
The Industrial Products sector appears to be quite strong. Let's take a sneak peek at four major Industrial stocks scheduled to report earnings tomorrow to see how things are shaping up for the upcoming results.
Cimpress Rides on Portfolio Restructuring, Risks Persist
by Zacks Equity Research
Cimpress' (CMPR) business is scalable and its web presence and online tools for customer use are well established, although foreign currency woes remain potential headwinds.
Bemis Rides on Restructuring Plan, Hurricane Effect a Woe
by Zacks Equity Research
Bemis' (BMS) restructuring plan will help align its manufacturing and administrative cost structures with current business environment. However, its results will be hurt by rising raw material prices.
New Strong Sell Stocks for October 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Cimpress (CMPR) Maintains Core Business Focus, Risks Remain
by Supriyo Bose
Cimpress N.V.'s (CMPR) business is scalable and its web presence and online tools for customer use are well established although foreign currency woes remain potential headwinds.
Cimpress (CMPR) Shows Long-Term Promise with Holistic Growth
by Zacks Equity Research
Cimpress N.V.'s (CMPR) business is scalable and its web presence and online tools for customer use are well established.
Cimpress (CMPR) Q4 Loss Wider than Expected, Revenues Beat
by Zacks Equity Research
Cimpress N.V. (CMPR) reports wider-than-expected loss due to the year-over-year impact of non-operational and non-cash currency.